Literature DB >> 19270724

Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.

H Lallet-Daher1, M Roudbaraki, A Bavencoffe, P Mariot, F Gackière, G Bidaux, R Urbain, P Gosset, P Delcourt, L Fleurisse, C Slomianny, E Dewailly, B Mauroy, J L Bonnal, R Skryma, N Prevarskaya.   

Abstract

Accumulating data point to K(+) channels as relevant players in controlling cell cycle progression and proliferation of human cancer cells, including prostate cancer (PCa) cells. However, the mechanism(s) by which K(+) channels control PCa cell proliferation remain illusive. In this study, using the techniques of molecular biology, biochemistry, electrophysiology and calcium imaging, we studied the expression and functionality of intermediate-conductance calcium-activated potassium channels (IK(Ca1)) in human PCa as well as their involvement in cell proliferation. We showed that IK(Ca1) mRNA and protein were preferentially expressed in human PCa tissues, and inhibition of the IK(Ca1) potassium channel suppressed PCa cell proliferation. The activation of IK(Ca1) hyperpolarizes membrane potential and, by promoting the driving force for calcium, induces calcium entry through TRPV6, a cation channel of the TRP (Transient Receptor Potential) family. Thus, the overexpression of the IK(Ca1) channel is likely to promote carcinogenesis in human prostate tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270724     DOI: 10.1038/onc.2009.25

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

1.  Effects of ibandronate sodium, a nitrogen-containing bisphosphonate, on intermediate-conductance calcium-activated potassium channels in osteoclast precursor cells (RAW 264.7).

Authors:  Sheng-Nan Wu; Yan-Ming Huang; Yu-Kai Liao
Journal:  J Membr Biol       Date:  2014-11-02       Impact factor: 1.843

Review 2.  Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.

Authors:  Noelle M Griffin; Jan E Schnitzer
Journal:  Mol Cell Proteomics       Date:  2010-06-14       Impact factor: 5.911

3.  Identification and functional characterization of the intermediate-conductance Ca(2+)-activated K(+) channel (IK-1) in biliary epithelium.

Authors:  Amal K Dutta; Al-karim Khimji; Meghana Sathe; Charles Kresge; Vinay Parameswara; Victoria Esser; Don C Rockey; Andrew P Feranchak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

4.  Regulation of the Ca(2+) channel TRPV6 by the kinases SGK1, PKB/Akt, and PIKfyve.

Authors:  Mentor Sopjani; Anja Kunert; Kamil Czarkowski; Fabian Klaus; Jörg Laufer; Michael Föller; Florian Lang
Journal:  J Membr Biol       Date:  2009-12-30       Impact factor: 1.843

5.  The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.

Authors:  J W Roy; E A Cowley; J Blay; P Linsdell
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

6.  Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.

Authors:  Glovioell W Rowland; Gary G Schwartz; Esther M John; Sue Ann Ingles
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

7.  Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells.

Authors:  Xiao-Wei Yang; Jin-Wen Liu; Ru-Chao Zhang; Qian Yin; Wen-Zhuang Shen; Ji-Lin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

8.  Bioelectric Control of Metastasis in Solid Tumors.

Authors:  Samantha L Payne; Michael Levin; Madeleine J Oudin
Journal:  Bioelectricity       Date:  2019-09-16

9.  KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34.

Authors:  B Bonito; D R P Sauter; A Schwab; M B A Djamgoz; I Novak
Journal:  Pflugers Arch       Date:  2016-10-17       Impact factor: 3.657

10.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.